HIV Prevention: Considerations for Adolescents and Young Adults

During the adolescent and young adult years, people are faced with significant physical and developmental changes ...

APRIL 30, 2025

HIV and Hemodialysis: Opportunity for Use of Single-Tablet Regimens

People living with HIV who are started on antiretroviral therapy are now living longer and enjoying a similar life ...

OCTOBER 18, 2023

More Research, Understanding Needed For Women With HIV

In 2020, there were 37.7 million women with HIV, comprising approximately half of the global population with HIV.

MAY 30, 2023

Lenacapavir: A Treatment Option For Multidrug-Resistant HIV

New treatments for people with multidrug-resistant (MDR) HIV are necessary to avoid hospitalization, progression to ...

MARCH 28, 2023

HIV and Incident Diabetes Mellitus

As HIV morbidity and mortality continue to decrease due to antiretroviral therapy (ART), attention has turned to ...

DECEMBER 10, 2022

Considerations in the Aging Population With HIV

The treatment of HIV has evolved over the last 40 years to a point where the life expectancies of people with HIV ...

OCTOBER 17, 2022

Current Options for Highly Treatment-Experienced People With HIV

The treatment of HIV has dramatically advanced over the past 40 years. Clear data show a decreased occurrence of ...

JUNE 22, 2022

Implementing Injectables: Considerations for Cabotegravir-Rilpivirine Long-Acting Therapy

Long-acting cabotegravir and rilpivirine injections are approved in Canada, Europe, and the United States.

JANUARY 7, 2022

Symtuza: First STR, PI-Based Therapy for HIV-1

The first major reduction in AIDS-related mortality came with the introduction of protease inhibitors (PIs) as part ...

OCTOBER 11, 2019